Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 29-35

  Ginobbi, P ^a   Geiser, T A ^b   Ombres, D ^a   Citro, G ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b ILLUMINA INC   (United States)

Author keywords

Antisense oligodeoxynucleotides; C myc; Melanoma

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; FOLIC ACID; MEMBRANE RECEPTOR; POLYLYSINE;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG UPTAKE; HUMAN; HUMAN CELL; LIGAND BINDING; MELANOMA; ONCOGENE C MYC; PRIORITY JOURNAL;

DRUG CARRIERS; ENDOCYTOSIS; FOLIC ACID; GENES, MYC; HUMANS; MELANOMA; OLIGONUCLEOTIDES, ANTISENSE; POLYLYSINE; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR CELLS, CULTURED;

EID: 0031044157     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wagner R W: Gene inhibition using antisense oligodeoxynucleotides. Nature 372: 333-335, 1994.
2. Stein CA and Cheng YC: Antisense oligonucleotides as therapeutic agents. Is the bullet really magical ?. Science 26: 1004-1011, 1993.
3. Stein CA, Subasiughe C, Shinozuke K and Cohen J: Physicochemical properties of phosphorotioate oligodeoxynucleotides. Nucleic Acid Res 16: 3209-3221, 1988
4. Citro G, Szczylik C, Ginobbi P, Zupi G and Calabretta B: Inhibition of leukemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells. Br J Cancer 69: 463-467, 1994.
5. Leamon CP and Low PS: Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA 88: 5572-5576, 1991.
6. Citro G, Perrotti D, Cucco C, D'Agnano I, Sacchi A, Zupi G and Calabretta B: Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 89: 7031-7035, 1992.
7. Versteeg R, Noordermeer AI, Kruse-Wolters M, Ruiter DJ and Schrier PI: c-myc down-regulates class I HLA expression in human melanoma. EMBO J 7: 1023-1029, 1988.
8. Peltenburg LT and Shier PI: Transcriptional suppression of HLA-B expression by c-myc is mediated through the core promoter elements. Immunogenetics 40: 54-61, 1994.
9. Richardson DR and Baker E: The release of iron and transferrin from the human melanoma cell. Biochim Biophys Acta 1091: 294-302, 1991.
10. Leonetti C D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G and Zupi G: Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice. J Nat Cane Institut 88: 419-429; 1996
11. Manfredini R, Grande A, Tagliafico E, Barbieri D, Zucchini P, Citro G, Zupi G, Franceshini C, Torelli U and Ferrari S: Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiation. J Exp Med 178: 381-389, 1993.
12. Soddu S, Blandino G, Citro G, Scardigli R, Piaggio G, Ferber A, Calabretta B and Sacchi A: Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells. Blood 83: 2230-2237, 1994.
13. Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D, Demeneix B and Behr JP: A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc Natl Acad Sci USA 92: 7297-7301, 1995.
14. Richardson D and Baker E: Two mechanisms of iron uptake from transferrin by melanoma cells. J Biol Chem 267: 13972-13979, 1992.
15. Asok CA: The biological chemestry of folate receptors. Blood 79: 2807-2820, 1992.
16. Klausner RD, Ashwell G, Van Renswonde J, Harford JB and Bridger KR: Binding of apotransferrin to K 562 cells: explanation of the transferrin cycle. Proc Natl Acad Sci USA 80: 263-266, 1983.
17. Weitman SD, Lark RH, Fort DW, Frasca V, Zurawski VR and Kamen BA: Distribuition of the folate receptor GP 38 in normal and malignant cell lines and tissues. Cancer Res 52: 3396-3401, 1992.
18. Chen J, Gamou S, Takayanagi A and Shimizu N: A novel gene delivery system using EGF receptor-mediated endocytosis. FEBS 338: 167-169, 1994.